OBJECTIVES

After successful completion of this course, attendees should be able to:

• Review significant advances in therapeutic options particularly biologics and
  immunomodulators in the treatment of IBD

• Discuss emerging genomic research developments as related to the pathophysiology of IBD
  

• Understand evolving patient management and treatment strategies for intestinal and extraintestinal complications in IBD

• Review immunological and microbial aspects relevant to the pathology of IBD
  

• Describe appropriate strategy options for the management of pediatric and adolescent patients with IBD
  

• Recommend disease management options based on current understanding of case presentations from national IBD thought leaders
  

• Discuss advantages and disadvantages of current pharmacological therapies for IBD
  

• Identify the most appropriate and effective surgical techniques in the treatment of IBD
  

• Review clinical challenges encountered by clinicians including the simple dichotomy between ulcerative colitis and Crohn’s disease toward enhancement of overall patient outcomes